Synapse - Tiffany Traina

Search Within

Tiffany A Traina

Results (68)

Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast

Meeting Abstract

Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
International Journal of Radiation Oncology, Biology, Physics (2021)

Fulltext@MSK | Save

PD-L1 expression in metaplastic breast carcinoma using the PD-L1 SP142 assay and concordance among PD-L1 immunohistochemical assays

Journal Article

Grabenstetter, A.; Jungbluth, A. A.; Frosina, D.; Hoda, R.; Dos Anjos, C. H.; Patil, S.; Sevilimedu, V.; Weigelt, B.; Reis-Filho, J. S.; Zhang, H.; more...
American Journal of Surgical Pathology (2021)

Fulltext@MSK | Save

PARP (poly ADP-ribose polymerase) inhibitors for locally advanced or metastatic breast cancer

Review

Taylor, A. M.; Chan, D. L. H.; Tio, M.; Patil, S. M.; Traina, T. A.; Robson, M. E.; Khasraw, M.
Cochrane Database of Systematic Reviews (2021)

Fulltext@MSK | Save

Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer

Meeting Abstract

Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients

Meeting Abstract

Barrios, D. M.; Wang, D. G.; Blinder, V. S.; Bromberg, J.; Drullinsky, P.; Funt, S. A.; Jhaveri, K. L.; Lake, D.; Lyons, T.; Modi, S.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma

Journal Article

Hoda, R. S.; Brogi, E.; Dos Anjos, C. H.; Grabenstetter, A.; Ventura, K.; Patil, S.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Traina, T.; more...
Modern Pathology (2020)

Fulltext@MSK | Save

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

Journal Article

Wang, D. G.; Barrios, D. M.; Blinder, V. S.; Bromberg, J. F.; Drullinsky, P. R.; Funt, S. A.; Jhaveri, K. L.; Lake, D. E.; Lyons, T.; Modi, S.; more...
Breast Cancer Research and Treatment (2020)

Fulltext@MSK | Save

Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Meeting Abstract

Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Genomic profiling of primary and metastatic breast cancer in men

Meeting Abstract

Drago, J. Z.; Serna-Tamayo, C.; Dos Anjos, C. H.; Brown, D. N.; Modi, S.; Jhaveri, K.; Solit, D. B.; Traina, T. A.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
Cancer Research (2020)

Fulltext@MSK | Save

PD-L1 expression in metaplastic breast carcinoma (MBC) using PD-L1 SP142 assay and concordance among PD-L1 immunohistochemical (IHC) assays

Meeting Abstract

Grabenstetter, A.; Jungbluth, A.; Frosina, D.; Hoda, R.; Weigelt, B.; Reis-Filho, J.; Zhang, H.; Traina, T.; Robson, M.; Brogi, E.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save